These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18799945)

  • 41. Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor.
    Wang WC; Cordoba J; Infante AJ; Conley ME
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):160-3. PubMed ID: 7513136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of bacterial infections in patients with advanced HIV infection.
    Mitsuyasu R
    AIDS; 1999; 13 Suppl 2():S19-23. PubMed ID: 10596677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of systematic administration of Filgrastim to prevent neutropenia and infections in patient with hepatitis C.
    Sharvadze L; Karchava M; Bolokadze N; Gatserelia L; Tsertsvadze T
    Georgian Med News; 2009 Oct; (175):32-5. PubMed ID: 19893121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eczema and X-linked agammaglobulinaemia.
    Hunter HL; McKenna KE; Edgar JD
    Clin Exp Dermatol; 2008 Mar; 33(2):148-50. PubMed ID: 18076688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Granulocyte colony-stimulating factor in the treatment of febrile neutropenia].
    López-Hernández MA; Jiménez-Alvarado R; Borbolla-Escoboza R; de Diego Flores-Chapa J; Alvarado-Ibarra M; González-Avante M; Trueba-Chrysti ME; Anaya-Cuéllar I
    Gac Med Mex; 2000; 136(2):99-105. PubMed ID: 10815320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
    Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [X-linked agammaglobulinemia in nine patients: review of the literature].
    Ganem MR; Pastorino AC; Jacob CM; Duarte AJ; Carneiro-Sampaio MM; Grumach AS
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(4):187-94. PubMed ID: 9567369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Granulocytic growth factors and cancer-related neutropenia: limited effects.
    Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia.
    Shahmahmoodi S; Parvaneh N; Burns C; Asghar H; Mamishi S; Tabatabaie H; Chen Q; Teimourian S; Gooya MM; Esteghamati AR; Mousavi T; Yousefi M; Farrokhi K; Mashlool M; Kew O; Nategh R
    Virus Res; 2008 Oct; 137(1):168-72. PubMed ID: 18674576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia.
    Waladkhani AR
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):371-9. PubMed ID: 15305906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival of wild polio by a patient with XLA.
    Sarpong S; Skolnick HS; Ochs HD; Futatani T; Winkelstein JA
    Ann Allergy Asthma Immunol; 2002 Jan; 88(1):59-60. PubMed ID: 11814279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.
    Nettagul R; Visitsunthorn N; Vichyanond P
    J Med Assoc Thai; 2003 Jul; 86(7):686-92. PubMed ID: 12948264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Dermatomyositis-like syndrome in x-linked agammaglobulinemia].
    Carvalho PD; Costa C; Rodrigues M; Salvador MJ; Pereira da Silva JA; Malcata A
    Acta Reumatol Port; 2016; 41(1):78-81. PubMed ID: 27115112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective study of 98 patients with X-linked agammaglobulinemia complicated with arthritis.
    Qing-Qi R; Ya-Wen L; Huan C; Yu Z; Yun-Fei A; Xue-Mei T; Xiao-Dong Z; Zhi-Yong Z
    Clin Rheumatol; 2022 Jun; 41(6):1889-1897. PubMed ID: 35171366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease.
    Tuzankina I; Kobeleva Y; Kiseleva N; Bolkov M; Reuter G; Maródi L
    Allergy; 2011 Dec; 66(12):1617-8. PubMed ID: 21951217
    [No Abstract]   [Full Text] [Related]  

  • 58. Evolving practice: X-linked agammaglobulinemia and lung transplantation.
    Barnes S; Kotecha S; Douglass JA; Paul E; Hore-Lacy F; Stirling R; Snell GI; Westall GP
    Am J Transplant; 2015 Apr; 15(4):1110-3. PubMed ID: 25736826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature.
    Devassikutty FM; Jain A; Edavazhippurath A; Joseph MC; Peedikayil MMT; Scaria V; Sandhya P; Govindaraj GM
    Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):115-118. PubMed ID: 34495748
    [No Abstract]   [Full Text] [Related]  

  • 60. Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia.
    Yoshino A; Honda M; Kanegane H; Obata K; Matsukura H; Sakazume S; Katada Y; Miyawaki T; Ueda Y; Nagai T
    Pediatr Nephrol; 2006 Jan; 21(1):36-8. PubMed ID: 16550363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.